Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 2
1994 2
1996 2
1997 1
1998 2
1999 2
2000 4
2001 7
2002 6
2003 5
2004 9
2005 5
2006 10
2007 15
2008 11
2009 5
2010 5
2011 9
2012 3
2013 3
2014 9
2015 6
2016 13
2017 6
2018 5
2019 4
2020 6
2021 4
2022 8
2023 4
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Results by year

Filters applied: . Clear all
Page 1
The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression.
Van den Eynde V, Abdelmoemin WR, Abraham MM, Amsterdam JD, Anderson IM, Andrade C, Baker GB, Beekman ATF, Berk M, Birkenhäger TK, Blackwell BB, Blier P, Blom MBJ, Bodkin AJ, Cattaneo CI, Dantz B, Davidson J, Dunlop BW, Estévez RF, Feinberg SS, Finberg JPM, Fochtmann LJ, Gotlib D, Holt A, Insel TR, Larsen JK, Mago R, Menkes DB, Meyer JM, Nutt DJ, Parker G, Rego MD, Richelson E, Ruhé HG, Sáiz-Ruiz J, Stahl SM, Steele T, Thase ME, Ulrich S, van Balkom AJLM, Vieta E, Whyte I, Young AH, Gillman PK. Van den Eynde V, et al. CNS Spectr. 2022 Jul 15:1-14. doi: 10.1017/S1092852922000906. Online ahead of print. CNS Spectr. 2022. PMID: 35837681 Review.
The guide suggests that MAOIs should always be considered in cases of treatment-resistant depression (including those melancholic in nature), and prior to electroconvulsive therapy-while taking into account of patient preference. In selected cases, they may be consi …
The guide suggests that MAOIs should always be considered in cases of treatment-resistant depression (including those melancholic in nature) …
Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions.
Elsayed OH, Ercis M, Pahwa M, Singh B. Elsayed OH, et al. Neuropsychiatr Dis Treat. 2022 Dec 16;18:2927-2943. doi: 10.2147/NDT.S273503. eCollection 2022. Neuropsychiatr Dis Treat. 2022. PMID: 36561896 Free PMC article. Review.
Celecoxib augmentation of escitalopram and treatment with metformin in patients with insulin resistance showed promising results. Right unilateral electroconvulsive therapy displayed statistically significant response rate and improvement, but not remission compared …
Celecoxib augmentation of escitalopram and treatment with metformin in patients with insulin resistance showed promising results. Right unil …
Electroconvulsive therapy and melancholia: review of the literature and suggestions for further study.
Rasmussen KG. Rasmussen KG. J ECT. 2011 Dec;27(4):315-22. doi: 10.1097/YCT.0b013e31820a9482. J ECT. 2011. PMID: 21673591 Review.
It has long been lore in the electroconvulsive therapy (ECT) field that melancholic depression is particularly responsive to ECT, whereas nonmelancholic depressions are less so. ...The first systematic studies of this subject in the 1950s and 1960s see …
It has long been lore in the electroconvulsive therapy (ECT) field that melancholic depression is particularly responsi …
Concurrent Electroconvulsive Therapy and Bupropion Treatment.
Takala CR, Leung JG, Murphy LL, Geske JR, Palmer BA. Takala CR, et al. J ECT. 2017 Sep;33(3):185-189. doi: 10.1097/YCT.0000000000000423. J ECT. 2017. PMID: 28570500
BACKGROUND: Bupropion is associated with a dose-dependent increased risk of seizures. Use of concomitant bupropion and electroconvulsive therapy (ECT) remains controversial because of an increased risk of prolonged seizures. ...Electroconvulsive the …
BACKGROUND: Bupropion is associated with a dose-dependent increased risk of seizures. Use of concomitant bupropion and electroconvulsive …
Electroconvulsive Therapy in Pregnancy: Safety, Best Practices, and Barriers to Care.
Rose S, Dotters-Katz SK, Kuller JA. Rose S, et al. Obstet Gynecol Surv. 2020 Mar;75(3):199-203. doi: 10.1097/OGX.0000000000000763. Obstet Gynecol Surv. 2020. PMID: 32232498 Review.
OBJECTIVE: The aim of this study is to review the current safety data on electroconvulsive therapy (ECT) in pregnancy and provide guidance to clinicians on the role of ECT in pregnancy and the special considerations for its use in our population. ...RE …
OBJECTIVE: The aim of this study is to review the current safety data on electroconvulsive therapy (ECT) in pregnancy a …
Malignant catatonia.
Philbrick KL, Rummans TA. Philbrick KL, et al. J Neuropsychiatry Clin Neurosci. 1994 Winter;6(1):1-13. doi: 10.1176/jnp.6.1.1. J Neuropsychiatry Clin Neurosci. 1994. PMID: 7908547 Review.
Preanesthesia medical evaluation for electroconvulsive therapy: a review of the literature.
Sundsted KK, Burton MC, Shah R, Lapid MI. Sundsted KK, et al. J ECT. 2014 Mar;30(1):35-42. doi: 10.1097/YCT.0b013e3182a3546f. J ECT. 2014. PMID: 24091900 Review.
OBJECTIVE: Electroconvulsive therapy (ECT) is widely used for the treatment of psychiatric disorders, yet there is few published literature to guide the practitioner in the preprocedural evaluation of patients. ...CONCLUSIONS: Although ECT is generally …
OBJECTIVE: Electroconvulsive therapy (ECT) is widely used for the treatment of psychiatric disorders, yet there is few …
Electric Field Modeling for Transcranial Magnetic Stimulation and Electroconvulsive Therapy.
Deng ZD, Liston C, Gunning FM, Dubin MJ, Fridgeirsson EA, Lilien J, van Wingen G, van Waarde J. Deng ZD, et al. 2019 Aug 28. In: Makarov S, Horner M, Noetscher G, editors. Brain and Human Body Modeling: Computational Human Modeling at EMBC 2018 [Internet]. Cham (CH): Springer; 2019. Chapter 4. 2019 Aug 28. In: Makarov S, Horner M, Noetscher G, editors. Brain and Human Body Modeling: Computational Human Modeling at EMBC 2018 [Internet]. Cham (CH): Springer; 2019. Chapter 4. PMID: 31725245 Free Books & Documents. Review.
There are two approved brain stimulation techniques for the treatment of MDD: electroconvulsive therapy (ECT) and repetitive transcranial magnetic stimulation (rTMS). The goal of this study is to quantify the induced electric field (E-field) at the dorsolater …
There are two approved brain stimulation techniques for the treatment of MDD: electroconvulsive therapy (ECT) and repet …
Finite Element Modelling Framework for Electroconvulsive Therapy and Other Transcranial Stimulations.
Ahmad Bakir A, Bai S, Lovell NH, Martin D, Loo C, Dokos S. Ahmad Bakir A, et al. 2019 Aug 28. In: Makarov S, Horner M, Noetscher G, editors. Brain and Human Body Modeling: Computational Human Modeling at EMBC 2018 [Internet]. Cham (CH): Springer; 2019. Chapter 2. 2019 Aug 28. In: Makarov S, Horner M, Noetscher G, editors. Brain and Human Body Modeling: Computational Human Modeling at EMBC 2018 [Internet]. Cham (CH): Springer; 2019. Chapter 2. PMID: 31725241 Free Books & Documents. Review.
Electroconvulsive therapy (ECT) is widely acknowledged as a highly effective treatment for major depressive disorder, and transcranial brain stimulation techniques in general are of great interest for therapeutic neuromodulation and neurostimulation. ...The c …
Electroconvulsive therapy (ECT) is widely acknowledged as a highly effective treatment for major depressive disorder, a …
Electroconvulsive therapy for the acute management of severe agitation in dementia (ECT-AD): A modified study protocol.
Lapid MI, Merrill J, Mueller M, Hermida AP, Nykamp L, Andrus J, Azizi H, Bolton P, Bonsu N, Braga R, Dillon CR, Ecklesdafer D, Evans D, Harper D, Heintz H, Hussain-Krauter S, Holzgen O, Humphrey D, Jiwani S, Johnson EK, Kang S, Kassien J, Kim J, Knapp RG, Kung S, Kremen N, Le K, Mahdasian J, Marzouk T, Masrud JD, Mattingly J, Miller D, Pagali SR, Patrick R, Riva Posse P, Pritchett C, Rahman A, Rath S, Roczniak C, Rummans TA, Sanghani S, Seiner S, Smart L, Tomaschek E, Tsygankova V, VanderSchuur-White L, Walton MP, Wilkins J, Williams A, Williams SM, Petrides G, Forester BP. Lapid MI, et al. PLoS One. 2024 Jun 28;19(6):e0303894. doi: 10.1371/journal.pone.0303894. eCollection 2024. PLoS One. 2024. PMID: 38941338 Free PMC article. Clinical Trial.
OBJECTIVE: This study began as a single-blind randomized controlled trial (RCT) to investigate the efficacy and safety of electroconvulsive therapy (ECT) for severe treatment-refractory agitation in advanced dementia. ...METHODS: Initially, the RCT randomized …
OBJECTIVE: This study began as a single-blind randomized controlled trial (RCT) to investigate the efficacy and safety of electroconvulsi …
173 results